BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: The Italian melanoma intergroup study

Journal of Clinical Oncology

Volumn 22, Issue 2, 2004, Pages 286-292

  Casula, Milena ^a   Colombino, Maria ^a   Satta, Maria P ^a   Cossu, Antonio ^a   Ascierto, Paolo A ^a   Bianchi Scarrà, Giovanna ^a   Castiglia, Daniele ^a   Budroni, Mario ^a   Rozzo, Carla ^a   Manca, Antonella ^a   Lissia, Amelia ^a   Carboni, Annangela ^a   Petretto, Elisabetta ^a   Satriano, Sabrina M R ^a   Botti, Gerardo ^a   Mantelli, Michela ^a   Ghiorzo, Paola ^a   Stratton, Michael R ^a   Tanda, Francesco ^a   Palmieri, Giuseppe ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; DNA; RAF PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE MUTATION; GENE SEQUENCE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MELANOMA; MUTATION RATE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SOMATIC MUTATION; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MULTICENTER STUDY; MUTATION; NUCLEOTIDE SEQUENCE; RISK FACTOR; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RISK FACTORS; SKIN NEOPLASMS;

EID: 1342268526     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.07.112     Document Type: Article

References (22)

1. Parkin DM, Whelan SL, Ferlay J, et al: Cancer incidence in five continents, Vol VIII. Lyon, France, IARC Press, 2003
2. Z. Bataille V: Genetic epidemiology of melanoma. Eur J Cancer 39:1341-1347, 2003
3. Gilchrest BA, Eller MS, Geller AC, et al: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-1348, 1999
4. Jhappan C, Noonan FP, Merlino G: Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22:3099-3112, 2003
5. Hayward NK: Genetics of melanoma predisposition. Oncogene 22:3053-3062, 2003
6. Soufir N, Avril M-F, Chompret A, et al: Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet 7:209-216, 1998
7. Aitken J, Welch J, Duffy D, et al: CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 91:446-452, 1999
8. Harland M, Holland EA, Ghiorzo P, et al: Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosom Cancer 28:45-57, 2000
9. Bishop DT, Demenais F, Goldstein AM, et al: Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94:894-903, 2002
10. Goldstein AM, Chidambaram A, Halpern A, et al: Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res 12:51-55, 2002
11. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 417:949-954, 2002
12. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 19:3635-3648, 2001
13. Haluska FG, Hodi FS: Molecular genetics of familial cutaneous melanoma. J Clin Oncol 16:670-682, 1998
14. Smith-Sorensen B, Hovig E: CDKN2A (p 16INK4A) somatic and germline mutations. Hum Mutat 7:294-303, 1996
15. Palmieri G, Palomba G, Cossu A, et al: BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. Ann Oncol 13:1899-1907, 2002
16. Cohen Y, Xing M, Mambo E, et al: BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627, 2003
17. Brose MS, Volpe P, Feldman M, et al: BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62:6997-7000, 2002
18. Yuen ST, Davies H, Chan TL, et al: Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451-6455, 2002
19. Mantelli M, Pastorino L, Ghiorzo P, et al: Frequency of CDKN2A mutation in Ligurian non-familial melanoma patients. Presented at third Research Meeting on Melanoma, Milan, Italy, May 26-28, 2003
20. Della Torre G, Pasini B, Frigerio S, et al: CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: Functional characterization of a novel CDKN2A germ line mutation. Br J Cancer 85:836-844, 2001
21. Mantelli M, Barile M, Ciotti P, et al: High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a) gene in 62 Italian malignant melanoma families. Am J Med Genet 107:214-221, 2002
22. Pollock PM, Harper UL, Hansen KS, et al: High frequency of BRAF mutations in nevi. Nat Genet 33:19-20, 2003